13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neuropharmacology and Neurochemistry
Neuropharmacology:
Neuropharmacology is the study of how drugs modify cellular function in the nervous system, and the neural mechanisms through which they oppress behavior.There are two main branches of neuropharmacology: behavioral and molecular. Behavioral neuropharmacology concentrate on the study of how drugs affect human behavior (neuropsychopharmacology), including the study of how drug dependence and addiction influence the human brain.Molecular neuropharmacology contains the study of neurons and their neurochemical interactions, with the overall goal of developing drugs that have beneficial effects on neurological function.
Neurochemistry:
Neurochemistry is the study of chemicals, involving neurotransmitters and other molecules such as psychopharmaceuticals and neuropeptides, that control and influence the physiology of the nervous system.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Toru Kondo
Hokkaido University, Japan
Isao Okunishi
Kinjirushi Co., Ltd, Japan
Thomas J Webster
Brown University, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Spring break: A true story of hope and determination
Steven Benvenisti, Davis, Saperstein Salomon, PC, United States
Title : The role of compromised cerebrospinal fluid circulation in sleep apnea
Joe Sam Robinson, Mercer University, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Nervous system effects in chemicals with immediately dangerous to life or health values
Sudha P Pandalai, National Institute for Occupational Safety and Health, United States
Title : Clinical outcomes of AI-augmented cognitive rehabilitation in dementia and mild cognitive impairment
Esra Al, NewDays, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States